NIH-funded research U01 cooperative agreement

Investigating how certain proteins affect heart disease in people with type 1 diabetes

Official title: Substance P Metabolites and Receptors in the Pathogenesis of Cardiac Disease in Type 1 Diabetes

Funded at West Virginia University · NIH-11074273 · Data updated 2026-11-12

This study is looking at how a protein called substance P might help protect the hearts of people with type 1 diabetes, and it hopes to find new ways to prevent or improve heart problems related to the condition.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWest Virginia University
NIH-funded
Lab location1 site (Morgantown, United States)
Project startSeptember 18, 2024
Project endJune 30, 2027
Funding year2024
Award (this year)$712,748
NIH project number1U01DK142329-01
Project IDNIH-11074273 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with type 1 diabetes who are at risk for cardiovascular complications.

Less likely to help

Patients without type 1 diabetes or those who do not have cardiovascular issues may not benefit from this research.

What this research studies

This research focuses on understanding the role of substance P and its metabolites in the development of heart disease among individuals with type 1 diabetes. The study uses animal models to explore how these proteins can protect against heart damage and improve heart function. By identifying new treatment approaches that target specific receptors involved in cardiac health, the research aims to find ways to prevent or reverse heart complications associated with diabetes.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent heart disease in patients with type 1 diabetes.

How similar studies have gone: Previous research has shown promising results in using similar approaches to protect heart health in diabetes, indicating potential for success in this study.

Where this research is happening

  • West Virginia University
    Morgantown, United States
    Active

Researchers

  • Principal investigator: Levick, Scott P — West Virginia University
  • Study coordinator: Levick, Scott P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.